Home » Directories » FDA Approved Drugs » Anzemet

Profile

Contact Information

Currently Enrolling Trials

General Information

Anzemet has been approved for the prevention of chemotherapy-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.

Approval Date: 1997-09-01

Company Name: Hoechst Marion Roussel

Back to Listings

26Jan
Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup
27Jan
Medical Device Clinical Trials in China: Latest Regulatory Developments
11Feb
Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era
23Mar
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
26Apr
MAGI's Clinical Research vConference — Spring 2021

Featured Products

Featured Stories

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here